Convatec Group PLC (FRA:2CV)

Market Cap	5.18B -11.4%
Revenue (ttm)	2.01B +7.1%
Net Income	184.52M +41.4%
EPS	0.09 +43.2%
Shares Out	n/a
PE Ratio	28.06
Forward PE	16.17
Dividend	0.06 (2.20%)
Ex-Dividend Date	Aug 21, 2025

Volume	n/a
Average Volume	35
Open	2.540
Previous Close	2.680
Day's Range	2.540 - 2.660
52-Week Range	2.420 - 3.520
Beta	n/a
RSI	43.53
Earnings Date	Feb 24, 2026

About Convatec Group

Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, bladder cancer, inflammatory b...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1978
• Employees: 10,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2CV

Financial Performance

In 2024, Convatec Group's revenue was $2.29 billion, an increase of 6.85% compared to the previous year's $2.14 billion. Earnings were $190.50 million, an increase of 46.20%.

Financial numbers in USD